Efficacy of denbufylline in patients with multi‐infarct dementia

Abstract
The efficacy and tolerance of denbufylline (25 and 50 mg tid for three months) were investigated in 20 inpatients with cerebrovascular disease in a placebo‐controlled, doubleblind parallel study. Denbufylline at 50 mg tid significantly improved the mental, emotional, and social capabilities of the patients; tolerance was acceptable.

This publication has 1 reference indexed in Scilit: